You will be shown a claim about public health, and the abstract of a biomedical research paper. Each sentence from the abstract will be on a separate line. Your task is to return a JSON object with two fields:

- "verdict": The fact-checking verdict. If the information in the abstract supports the claim, write "SUPPORT". If the abstract contradicts the claim, write "CONTRADICT". If the abstract does not provide enough information to arrive at a verdict, write "NEI" (for "not enough information").
- "evidence": An array of sentences providing evidence for the verdict. Please copy all relevant sentences verbatim from the abstract. If the verdict was "NEI", then return an empty array.

For instance, if the model were given the claim "wearing masks can prevent the spread of COVID", the output might be
{
  "verdict": "SUPPORT",
  "evidence": ["Our findings indicate that mass mask-wearing reduces the transmission rate for COVID-19."]
}

Claim: Dexamethasone cures covid-19

Abstract:
Background: Dexamethasone, a synthetic glucocorticoid, has anti-inflammatory and immunosuppressive properties.
There is a hyperinflammatory response involved in the clinical course of patients with pneumonia due to SARS-CoV2.
To date, there has been no definite therapy for COVID-19.
We reviewed the charts of SARS-CoV2 patients with pneumonia and moderate to severely elevated CRP and worsening hypoxemia who were treated with early, short-term dexamethasone.
Methods: We describe a series of 21 patients who tested positive for SARS-CoV2 and were admitted to The Miriam Hospital in Providence and were treated with a short course of dexamethasone, either alone or in addition to current investigative therapies.
Results: CRP levels decreased significantly following the start of dexamethasone from mean initial levels of 129.52 to 40.73 mg/L at time of discharge.
71% percent of the patients were discharged home with a mean length of stay of 7.8 days.
None of the patients had escalation of care, leading to mechanical ventilation.
Two patients were transferred to inpatient hospice facilities on account of persistent hypoxemia, in line with their documented goals of care.
Conclusions: A short course of systemic corticosteroids among inpatients with SARS-CoV2 with hypoxic respiratory failure was well tolerated, and most patients had improved outcomes.
This limited case series may not offer concrete evidence towards the benefit of corticosteroids in COVID-19.
However, patients positive response to short-term corticosteroids demonstrates that they may help blunt the severity of inflammation and prevent a severe hyperinflammatory phase, in turn reducing the length of stay, ICU admissions, and healthcare costs.
{"verdict": "CONTRADICT", "evidence": ["To date, there has been no definite therapy for COVID-19."]}